To determine whether the histone acetyltransferase activity of KAT2B is involved in the regulation of NF2 expression, we treated KAT2B stably overexpressed CCA cells with two different KAT2B histone acetyltransferase inhibitors, CPTH6 and L-Moses. Here, NF2 is linked to cholangiocarcinoma.